Logo

Piramal Pharma Ltd. Share Price

Pharmaceuticals & Drugs

Piramal Pharma Ltd. (INR)206.150.4   (0.2%)

Exchange ScripsBSE543635NSEPPLPHARMAISININE0DK501011

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Piramal Pharma Ltd. Performance

Market performance

Open price206.4
High208.28
Volumes2415290
Prev Close206.15
Low204.7
Closing date2025-05-21

Historical performance

1 Year High307.90
3 Year High307.90
5 Year High307.90
1 Year Low136.10
3 Year Low61.62
5 Year Low61.62

Piramal Pharma Ltd. Fundamentals

Company Valuation

Market Cap
Market Cap (₹Cr)
27217
Face Value
Face Value (₹)
10
P/E Ratio
P/E Ratio
1530.44
Dividend Yield
Dividend Yield
0.01 %

Piramal Pharma Ltd. Investment Returns

1 Year
40.2%
3 Years
N/A
5 Years
N/A
10 Years
N/A

Piramal Pharma Ltd. Technicals

IndicatorsValueSignal
5-DMA206.17Bearish
10-DMA209.05Bearish
20-DMA211.59Bearish
50-DMA214.26Bearish
100-DMA221.03Bearish
200-DMA225.19Bearish

Shareholding Pattern

FieldMar-2025Dec-2024Sep-2024Jun-2024Mar-2024
Promoters1717171717
Foreign Investors---------------
Domestic Investors1717171717
Public Investors432826418425359734306381297979
Government32112

Piramal Pharma Ltd. Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Other Income2011225127581641
Operating Profit1371785331225515921
Interest4485344219821634
Depreciation7406676758625450
Profit Before Tax1793-120248509490
Consolidated Net Profit178-186537608350
Adjusted EPS----238

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Share Capital1322911933118599946
Total Reserves65610558025510746103
Minority Interest------------
Total Non-Current Liabilities29288381202902625604
Total Liabilities152972144365127172107561
Capital Work in Progress5657852967323995
Total Assets152972144365127172107561

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Cash Flow from Operating Activities10045483976645976
Cash Flow from Investing Activities-4340-13388-18121-44799
Cash Flow from Financing Activitie-42248178794239768
Net Cash Inflow / Outflow1482-371-2515945
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 1530.44.
  • 3Y Stock Price CAGR of the stock is 5.4.
  • The stock has a beta of 0.7.
  • In the last financial year, the company had an EBITDA of ₹13717 Million.
  • The company generated revenue of ₹81712 Million in the previous financial year.

Piramal Pharma Ltd.

206.150.4   (0.2%)

Investment Amount: ₹ 1000000
Current Value: ₹ 1402381
No. of Shares: 6802.7
Performance:40.2%
P/L: ₹402381

Top Gainers

SymbolChange%
ABINFRA133.51(20%)
GROBTEA1112.5(20%)
TTML69.09(19%)
ECOSMOBLTY275.19(15%)
TRIDENT33.48(14%)

Top Losers

SymbolChange%
RADIOCITY9.44(-13%)
THEMISMED142.34(-11%)
FCL231.87(-10%)
GULPOLY193.87(-8%)
DHUNINV1468(-7%)
SRM392.6(-7%)
KRYSTAL647.9(-7%)
ONEPOINT64.77(-7%)

Similar stocks

Suven Life Sciences Ltd.

66.6

211.77

April 21 - May 21

Kilitch Drugs (India) Ltd.

33.2

471.75

April 21 - May 21

Aarti Drugs Ltd.

31

473.8

April 21 - May 21

IOL Chemicals And Pharmaceuticals Ltd.

27.4

86.27

April 21 - May 21

NGL Fine-Chem Ltd.

23.1

1285.6

April 21 - May 21

Aarti Pharmalabs Ltd.

22.8

875.1

April 21 - May 21

Morepen Laboratories Ltd.

22.3

65.94

April 21 - May 21

Anuh Pharma Ltd.

21.6

211.35

April 21 - May 21

Announcing Stock of the Month!

Stock of the Month
Stock of the Month